Agustin Melian - 05 Apr 2021 Form 4 Insider Report for Allovir, Inc. (KLRS)

Role
Chief Medical Officer
Signature
/s/ Brett Hagen, as Attorney-in-Fact
Issuer symbol
KLRS
Transactions as of
05 Apr 2021
Net transactions value
-$896,685
Form type
4
Filing time
20 Sep 2021, 16:05:10 UTC
Next filing
29 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALVR Common Stock Sale $435,085 -18,212 -3.5% $23.89* 498,304 05 Apr 2021 Direct F1
transaction ALVR Common Stock Sale $371,534 -18,586 -3.7% $19.99* 479,718 02 Jul 2021 Direct F1
transaction ALVR Common Stock Sale $19,224 -800 -0.17% $24.03* 478,918 15 Sep 2021 Direct F2, F3
transaction ALVR Common Stock Sale $70,842 -2,950 -0.62% $24.01* 475,968 17 Sep 2021 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock, and does not represent a discretionary trade by the reporting person.
F2 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.08. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.